|
Market Closed -
Nasdaq
16:00:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 3.770 USD | +5.31% |
|
+0.80% | +134.16% |
| 08-17 | B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | MT |
| 08-13 | MacroGenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: MacroGenics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 983.2 | 412.5 | 596.7 | 204 | 101.8 | 228 | - | - |
| Change | - | -58.04% | 44.66% | -65.82% | -50.07% | 123.91% | - | - |
| Enterprise Value (EV) | 983.2 | 412.5 | 366.9 | 204 | 101.8 | 228 | 228 | 228 |
| Change | - | -58.04% | -11.05% | -44.41% | -50.07% | 123.91% | 0% | 0% |
| P/E | -4.76x | -3.44x | -64.1x | -3.04x | -1.36x | -2.42x | -2.3x | -1.84x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0.7x | -0x | -0.1x | -0.1x | -0.44x | -0.1x |
| Capitalization / Revenue | 12.7x | 2.71x | 10.2x | 1.36x | 0.68x | 2.11x | 2.52x | 2.53x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.11x | 2.52x | 2.53x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.47x | -1.74x | -1.36x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -2.71x | -1.64x | -1.74x |
| FCF Yield | -15.3% | -22% | -13.4% | -35.3% | -81.5% | -36.8% | -61% | -57.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.37 | -1.95 | -0.15 | -1.07 | -1.18 | -1.558 | -1.64 | -2.049 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 77.45 | 151.9 | 58.75 | 150 | 149.5 | 108.2 | 90.61 | 90.12 |
| EBITDA | -191.5 | -109.6 | -158.6 | - | - | - | - | - |
| EBIT 1 | -202.8 | -121.4 | -168.2 | -110.6 | -72.84 | -92.47 | -130.9 | -167.6 |
| Net income 1 | -202.1 | -119.8 | -9.058 | -66.97 | -74.62 | -88.7 | -138.1 | -180.5 |
| Net Debt | - | - | -229.8 | - | - | - | - | - |
| Reference price 2 | 16.050 | 6.710 | 9.620 | 3.250 | 1.610 | 3.770 | 3.770 | 3.770 |
| Nbr of stocks (in thousands) | 61,258 | 61,475 | 62,029 | 62,763 | 63,259 | 63,700 | - | - |
| Announcement Date | 2/24/22 | 3/15/23 | 3/7/24 | 3/20/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.3x | - | - | - | 228M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 18.65x | 31.37x | 12.47x | 0.31% | 39.08B | |
| Weighted average by Cap. | 22.26x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MGNX Stock
- Valuation MacroGenics, Inc.
Select your edition
All financial news and data tailored to specific country editions
